{"output": [["Novartis", "COMP", "Produce", "Promacta", "PRODUCT"], ["Promacta", "PRODUCT", "Receive", "Breakthrough Therapy Designation", "EVENT"], ["Promacta", "PRODUCT", "Use", "Severe Aplastic Anemia", "CONCEPT"], ["Promacta", "PRODUCT", "Use", "Standard Immunosuppressive Therapy", "PRODUCT"], ["Promactis", "PRODUCT", "Approve", "Second-line Therapy", "CONCEPT", "Severe Aplastic Anemia", "CONCEPT"], ["Promacta", "PRODUCT", "Approve", "Chronic Immune Thrombocytopenia", "CONCEPT"], ["Promacta", "PRODUCT", "Impact", "Serious or Life Threatening Illness", "CONCEPT"], ["Novartis", "COMP", "Expect", "Regulatory Filings", "EVENT", "United States", "GPE", "European Union", "GPE"]], "published": "2018-01-04T08:53:00.000+02:00"}